| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | DNA replication | 1.94e-05 | 312 | 99 | 9 | GO:0006260 | |
| GeneOntologyBiologicalProcess | maturation of 5.8S rRNA | 2.92e-05 | 37 | 99 | 4 | GO:0000460 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 4.68e-05 | 15 | 99 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 4.68e-05 | 15 | 99 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 8.31e-05 | 18 | 99 | 3 | GO:0000479 | |
| GeneOntologyBiologicalProcess | protein localization to nucleolus | 9.83e-05 | 19 | 99 | 3 | GO:1902570 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 1.36e-04 | 163 | 99 | 6 | GO:0007093 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | NPM1 BRPF3 SLF1 NOP53 DTL DUT BARD1 BCCIP TFIP11 TTF1 FAM111B WIZ N4BP2 PRKDC POLQ | 1.93e-04 | 1081 | 99 | 15 | GO:0006259 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | MYH10 MCPH1 NOP53 DTL BARD1 BCCIP RRS1 HASPIN MKI67 PRKDC EML1 IK EXOC4 | 2.21e-04 | 854 | 99 | 13 | GO:1903047 |
| GeneOntologyBiologicalProcess | hypersensitivity | 2.28e-04 | 25 | 99 | 3 | GO:0002524 | |
| GeneOntologyBiologicalProcess | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.57e-04 | 26 | 99 | 3 | GO:0000466 | |
| Domain | WD40 | 9.63e-06 | 259 | 99 | 9 | PF00400 | |
| Domain | Copine | 1.19e-05 | 9 | 99 | 3 | PF07002 | |
| Domain | Copine | 1.19e-05 | 9 | 99 | 3 | IPR010734 | |
| Domain | WD40 | 1.27e-05 | 268 | 99 | 9 | SM00320 | |
| Domain | WD40_repeat | 1.42e-05 | 272 | 99 | 9 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.69e-05 | 278 | 99 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.74e-05 | 279 | 99 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.74e-05 | 279 | 99 | 9 | PS50294 | |
| Domain | WD40_repeat_dom | 2.85e-05 | 297 | 99 | 9 | IPR017986 | |
| Domain | - | 6.92e-05 | 333 | 99 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 7.24e-05 | 335 | 99 | 9 | IPR015943 | |
| Domain | Nucleoplasmin | 1.66e-04 | 4 | 99 | 2 | IPR004301 | |
| Domain | BRCT | 2.07e-04 | 22 | 99 | 3 | SM00292 | |
| Domain | - | 2.37e-04 | 23 | 99 | 3 | 3.40.50.10190 | |
| Domain | Myosin_S1_N | 2.75e-04 | 5 | 99 | 2 | IPR008989 | |
| Domain | BRCT | 3.44e-04 | 26 | 99 | 3 | PS50172 | |
| Domain | HELP | 4.11e-04 | 6 | 99 | 2 | PF03451 | |
| Domain | HELP | 4.11e-04 | 6 | 99 | 2 | IPR005108 | |
| Domain | BRCT_dom | 4.30e-04 | 28 | 99 | 3 | IPR001357 | |
| Domain | Myosin_head_motor_dom | 1.07e-03 | 38 | 99 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.07e-03 | 38 | 99 | 3 | PS51456 | |
| Domain | Myosin_head | 1.07e-03 | 38 | 99 | 3 | PF00063 | |
| Domain | MYSc | 1.07e-03 | 38 | 99 | 3 | SM00242 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.79e-03 | 53 | 99 | 3 | IPR011047 | |
| Domain | RUN | 4.03e-03 | 18 | 99 | 2 | SM00593 | |
| Domain | RUN | 4.48e-03 | 19 | 99 | 2 | PS50826 | |
| Domain | RUN | 4.48e-03 | 19 | 99 | 2 | PF02759 | |
| Domain | BRCT | 4.48e-03 | 19 | 99 | 2 | PF00533 | |
| Domain | Run_dom | 4.48e-03 | 19 | 99 | 2 | IPR004012 | |
| Domain | P-loop_NTPase | MYH10 ABCF1 MYO5B MYO9A DYNC2H1 SRPRB TRANK1 N4BP2 N4BP2L2 DDX60L POLQ | 5.24e-03 | 848 | 99 | 11 | IPR027417 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NPM1 MYH10 ABCF1 DYNC2H1 NOP53 COPB2 DUT KRI1 BCCIP LYAR AP3B1 PGD SRPRB PRDM2 RRS1 MKI67 PUM3 TAGLN2 PRKDC LTF IK SNRPB NUP153 | 1.91e-11 | 1425 | 102 | 23 | 30948266 |
| Pubmed | NPM1 CPNE8 ABCF1 EMC3 TAPT1 DYNC2H1 PPFIBP1 RANBP3 KRI1 APEH BCCIP TFIP11 AP3B1 PGD SRPRB SNX29 LACTB DNAJC28 RRS1 N4BP2 CCDC138 DNAJB2 EXOC4 | 4.46e-11 | 1487 | 102 | 23 | 33957083 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NPM1 CPNE8 MYH10 ABCF1 MYO5B NOP53 PPFIBP1 KRI1 LYAR SRPRB LACTB RRS1 AHNAK MKI67 PUM3 C3 PRKDC LTF IK SNRPB NUP153 | 8.85e-11 | 1257 | 102 | 21 | 36526897 |
| Pubmed | NPM1 MYH10 ABCF1 NOP53 COPB2 KRI1 TTF1 RRS1 AHNAK MKI67 PUM3 PRKDC LTF IK NUP153 | 8.38e-10 | 653 | 102 | 15 | 22586326 | |
| Pubmed | 8.58e-10 | 215 | 102 | 10 | 35973513 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NPM1 MYH10 ABCF1 RANBP3 GPATCH1 DUT TFIP11 MOB3A SNX29 WIZ RRS1 AHNAK MKI67 NCOA7 TAGLN2 PRKDC NUP153 | 1.93e-09 | 934 | 102 | 17 | 33916271 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.20e-08 | 283 | 102 | 10 | 30585729 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NPM1 SLF1 NOP53 GPATCH1 KRI1 TFIP11 LYAR WIZ RRS1 AHNAK MKI67 PUM3 PRKDC IK SNRPB NUP153 | 1.90e-08 | 954 | 102 | 16 | 36373674 |
| Pubmed | NPM1 MYH10 NOP53 DUT KRI1 BCCIP TFIP11 LYAR WIZ RRS1 MKI67 PUM3 PRKDC IK NUP153 | 2.71e-08 | 847 | 102 | 15 | 35850772 | |
| Pubmed | CPNE8 MYH10 EMC3 NOP53 PPFIBP1 COPB2 DUT KRI1 LYAR SRPRB RRS1 AHNAK MKI67 PUM3 DDX60L PRKDC LTF SNRPB EXOC4 | 3.57e-08 | 1440 | 102 | 19 | 30833792 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 3.65e-08 | 410 | 102 | 11 | 26949251 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NPM1 ABCF1 NOP53 COPB2 BARD1 KRI1 LYAR TTF1 RRS1 MKI67 PUM3 PRKDC IK EXOC4 | 4.99e-08 | 759 | 102 | 14 | 35915203 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NPM1 MYH10 ABCF1 MYO9A COPB2 TFIP11 LYAR PGD SRPRB RRS1 AHNAK MKI67 PUM3 DDX60L PRKDC LTF IK EXOC4 | 7.61e-08 | 1353 | 102 | 18 | 29467282 |
| Pubmed | 1.89e-07 | 483 | 102 | 11 | 36912080 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NPM1 MYH10 NOP53 DUT KRI1 TFIP11 LYAR RRS1 AHNAK MKI67 PUM3 TAGLN2 PRKDC IK NUP153 | 2.01e-07 | 989 | 102 | 15 | 36424410 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NPM1 MYH10 ABCF1 KRI1 TFIP11 LYAR MKI67 PUM3 PRKDC LTF IK SNRPB | 2.24e-07 | 605 | 102 | 12 | 28977666 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NPM1 MYH10 ABCF1 KRI1 BCCIP TFIP11 LYAR AP3B1 TTF1 SRPRB RRS1 AHNAK MKI67 TAGLN2 PRKDC SNRPB NUP153 | 2.83e-07 | 1318 | 102 | 17 | 30463901 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NPM1 CPNE8 ABCF1 EMC3 MYO5B SRPRB RRS1 AHNAK MKI67 PUM3 TAGLN2 PRKDC IK SNRPB NUP153 | 3.13e-07 | 1024 | 102 | 15 | 24711643 |
| Pubmed | NPM1 CPNE8 MYH10 KRI1 BCCIP TFIP11 LYAR AP3B1 TTF1 SRPRB LACTB RRS1 AHNAK MKI67 PUM3 TAGLN2 SNRPB | 4.90e-07 | 1371 | 102 | 17 | 36244648 | |
| Pubmed | NPM1 BARD1 LYAR RRS1 AHNAK MKI67 PUM3 C3 TAGLN2 PRKDC LTF SNRPB | 4.96e-07 | 652 | 102 | 12 | 31180492 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NPM1 MYH10 ABCF1 NOP53 COPB2 LYAR FAM111B AHNAK MKI67 C3 PRKDC LTF IK SNRPB | 7.40e-07 | 949 | 102 | 14 | 36574265 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NPM1 MYH10 ABCF1 EMC3 PPFIBP1 COPB2 DUT KRI1 TFIP11 LYAR AP3B1 SRPRB AHNAK TAGLN2 PRKDC IK SNRPB | 7.58e-07 | 1415 | 102 | 17 | 28515276 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 7.75e-07 | 341 | 102 | 9 | 32971831 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | NPM1 MYH10 PPFIBP1 RANBP3 COPB2 BCCIP BCAS1 LYAR AP3B1 SRPRB TLE1 TAGLN2 LTF POLQ SNRPB EXOC4 | 1.04e-06 | 1284 | 102 | 16 | 17353931 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NPM1 SLF1 MCPH1 GPATCH1 BARD1 TFIP11 LYAR TTF1 SRPRB PRDM2 WIZ AHNAK MKI67 PRKDC IK NUP153 | 1.15e-06 | 1294 | 102 | 16 | 30804502 |
| Pubmed | 1.60e-06 | 121 | 102 | 6 | 22412018 | ||
| Pubmed | 2.03e-06 | 9 | 102 | 3 | 9430674 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.44e-06 | 130 | 102 | 6 | 35545047 | |
| Pubmed | NPM1 EFCAB6 NOP53 PPFIBP1 GPATCH1 APEH AP3B1 SRPRB WIZ AHNAK MKI67 PRKDC | 3.06e-06 | 777 | 102 | 12 | 35844135 | |
| Pubmed | 3.57e-06 | 653 | 102 | 11 | 33742100 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MYH10 ABCF1 DYNC2H1 COPB2 WDR81 AP3B1 ZZEF1 PGD AHNAK TAGLN2 PRKDC EML1 | 4.50e-06 | 807 | 102 | 12 | 30575818 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.20e-06 | 440 | 102 | 9 | 34244565 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 6.30e-06 | 235 | 102 | 7 | 30258100 | |
| Pubmed | 6.32e-06 | 441 | 102 | 9 | 31239290 | ||
| Pubmed | 6.98e-06 | 156 | 102 | 6 | 22952844 | ||
| Pubmed | 7.59e-06 | 340 | 102 | 8 | 29478914 | ||
| Pubmed | 7.63e-06 | 242 | 102 | 7 | 34011540 | ||
| Pubmed | NPM1 ABCF1 COPB2 LYAR PARP14 SRPRB C3 DDX60L PRKDC LTF SNRPB | 7.97e-06 | 711 | 102 | 11 | 33022573 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 2531080 | ||
| Pubmed | GLTSCR2 is an upstream negative regulator of nucleophosmin in cervical cancer. | 8.52e-06 | 2 | 102 | 2 | 25818168 | |
| Pubmed | High expression of CPNE5 and CPNE9 predicts positive prognosis in multiple myeloma. | 8.52e-06 | 2 | 102 | 2 | 33780365 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20338617 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 9516136 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 9.17e-06 | 349 | 102 | 8 | 25665578 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | COPB2 AP3B1 SRPRB LACTB WIZ RRS1 AHNAK MKI67 TAGLN2 IK EXOC4 | 9.44e-06 | 724 | 102 | 11 | 36232890 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.08e-05 | 357 | 102 | 8 | 37059091 | |
| Pubmed | MYH10 EMC3 MYO5B NOP53 COPB2 KRI1 AP3B1 WIZ AHNAK CCDC138 MKI67 IK NUP153 | 1.24e-05 | 1049 | 102 | 13 | 27880917 | |
| Pubmed | 1.56e-05 | 494 | 102 | 9 | 26831064 | ||
| Pubmed | 1.57e-05 | 106 | 102 | 5 | 12429849 | ||
| Pubmed | 1.96e-05 | 641 | 102 | 10 | 36057605 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 2.12e-05 | 647 | 102 | 10 | 26618866 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.19e-05 | 394 | 102 | 8 | 27248496 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NPM1 ABCF1 RANBP3 COPB2 DUT APEH BCCIP AP3B1 ZZEF1 PGD METTL1 AHNAK NCOA7 PRKDC SNRPB | 2.23e-05 | 1455 | 102 | 15 | 22863883 |
| Pubmed | 2.45e-05 | 290 | 102 | 7 | 32929329 | ||
| Pubmed | Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo. | 2.55e-05 | 3 | 102 | 2 | 22065769 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23833235 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 20513429 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 37626903 | ||
| Pubmed | Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease. | 2.55e-05 | 3 | 102 | 2 | 37924979 | |
| Pubmed | Primary cilia are not required for normal canonical Wnt signaling in the mouse embryo. | 2.55e-05 | 3 | 102 | 2 | 19718259 | |
| Pubmed | Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies. | 2.55e-05 | 3 | 102 | 2 | 32142680 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 26133275 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 28556411 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 33951431 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 12361980 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 16520097 | ||
| Pubmed | Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus. | 2.55e-05 | 3 | 102 | 2 | 23261299 | |
| Pubmed | Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase. | 2.55e-05 | 3 | 102 | 2 | 15184379 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 25956029 | ||
| Pubmed | Functional Fcgamma receptor polymorphisms are associated with human allergy. | 2.55e-05 | 3 | 102 | 2 | 24586589 | |
| Pubmed | Biochemical characterization of copine: a ubiquitous Ca2+-dependent, phospholipid-binding protein. | 2.55e-05 | 3 | 102 | 2 | 11123945 | |
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 2.62e-05 | 58 | 102 | 4 | 37117185 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.02e-05 | 202 | 102 | 6 | 33005030 | |
| Pubmed | 3.46e-05 | 547 | 102 | 9 | 37267103 | ||
| Pubmed | 3.56e-05 | 549 | 102 | 9 | 38280479 | ||
| Pubmed | 3.56e-05 | 208 | 102 | 6 | 11790298 | ||
| Pubmed | 3.66e-05 | 551 | 102 | 9 | 34728620 | ||
| Pubmed | NPM1 CPNE8 ABCF1 CPNE9 MYO9A DUT NEB AHNAK MKI67 TAGLN2 PRKDC | 3.86e-05 | 844 | 102 | 11 | 25963833 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CPNE8 MYH10 ABCF1 PPFIBP1 GPATCH1 KRI1 BCCIP LYAR N4BP2 CCDC138 EXOC4 | 4.25e-05 | 853 | 102 | 11 | 28718761 |
| Pubmed | NPM1 MYO9A PPFIBP1 COPB2 AP3B1 SRPRB AHNAK PRKDC NUP153 EXOC4 | 4.54e-05 | 708 | 102 | 10 | 39231216 | |
| Pubmed | 4.62e-05 | 568 | 102 | 9 | 37774976 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 9693045 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 23749409 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 36759517 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 15308121 | ||
| Pubmed | Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. | 5.09e-05 | 4 | 102 | 2 | 16286018 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 34352206 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 23351466 | ||
| Pubmed | A critical role for Fc gamma RIIB in the induction of rheumatoid factors. | 5.09e-05 | 4 | 102 | 2 | 15383609 | |
| Pubmed | Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. | 5.09e-05 | 4 | 102 | 2 | 17446931 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 34536564 | ||
| Pubmed | FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival. | 5.09e-05 | 4 | 102 | 2 | 22516957 | |
| Pubmed | Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP? | 5.09e-05 | 4 | 102 | 2 | 21045192 | |
| Pubmed | Identification of proteins highly expressed in uterine fluid from mice with hydrometra. | 5.09e-05 | 4 | 102 | 2 | 26393907 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 27173733 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 25657202 | ||
| Pubmed | 5.24e-05 | 327 | 102 | 7 | 31409639 | ||
| Pubmed | 5.55e-05 | 330 | 102 | 7 | 32529326 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 5.57e-05 | 582 | 102 | 9 | 20467437 | |
| Pubmed | 5.76e-05 | 332 | 102 | 7 | 25693804 | ||
| Interaction | CIT interactions | NPM1 MYH10 ABCF1 TAPT1 DYNC2H1 NOP53 COPB2 KRI1 TFIP11 LYAR CPNE5 ZZEF1 LACTB RRS1 AHNAK HASPIN MKI67 PUM3 DDX60L PRKDC IK SNRPB NUP153 | 5.96e-07 | 1450 | 101 | 23 | int:CIT |
| Interaction | SIRT7 interactions | NPM1 MYH10 ABCF1 NOP53 COPB2 KRI1 LYAR TTF1 RRS1 AHNAK MKI67 PUM3 PRKDC LTF IK NUP153 | 8.68e-07 | 744 | 101 | 16 | int:SIRT7 |
| Interaction | CHMP4C interactions | NPM1 MYH10 ABCF1 MYO9A COPB2 KRI1 LYAR PGD RRS1 WDR87 AHNAK MKI67 TAGLN2 PRKDC SNRPB | 1.64e-06 | 687 | 101 | 15 | int:CHMP4C |
| Interaction | H3C1 interactions | NPM1 MYH10 PHF19 DYNC2H1 BARD1 KRI1 BCCIP NEB ZZEF1 PRDM2 WIZ WDR87 AHNAK HASPIN MKI67 PRKDC IK | 2.28e-06 | 901 | 101 | 17 | int:H3C1 |
| Interaction | PRR11 interactions | 4.11e-06 | 130 | 101 | 7 | int:PRR11 | |
| Interaction | MKI67 interactions | NPM1 NOP53 BARD1 KRI1 TFIP11 LYAR PARP14 TTF1 RRS1 HASPIN MKI67 PUM3 IK FGFBP1 | 4.27e-06 | 648 | 101 | 14 | int:MKI67 |
| Interaction | SRSF5 interactions | NPM1 NOP53 BARD1 KRI1 LYAR TTF1 ZNF800 RRS1 MKI67 PUM3 IK FGFBP1 | 4.47e-06 | 474 | 101 | 12 | int:SRSF5 |
| Interaction | BICD1 interactions | 4.66e-06 | 250 | 101 | 9 | int:BICD1 | |
| Interaction | SRPK3 interactions | 5.15e-06 | 190 | 101 | 8 | int:SRPK3 | |
| Interaction | SRSF1 interactions | NPM1 TRAF5 NOP53 DTL BARD1 KRI1 APEH LYAR RRS1 PUM3 PRKDC IK SNRPB | 5.42e-06 | 570 | 101 | 13 | int:SRSF1 |
| Interaction | SLX4 interactions | NPM1 NOP53 GPATCH1 DUT BARD1 AP3B1 WIZ MKI67 TAGLN2 PRKDC IK POLQ NUP153 | 5.63e-06 | 572 | 101 | 13 | int:SLX4 |
| Interaction | NAA40 interactions | NPM1 MYH10 ABCF1 RANBP3 GPATCH1 DUT TFIP11 MOB3A SNX29 WIZ RRS1 AHNAK MKI67 NCOA7 TAGLN2 PRKDC NUP153 | 6.81e-06 | 978 | 101 | 17 | int:NAA40 |
| Interaction | CCDC137 interactions | 7.51e-06 | 200 | 101 | 8 | int:CCDC137 | |
| Interaction | BIRC3 interactions | NPM1 ABCF1 DYNC2H1 NOP53 COPB2 DUT KRI1 BCCIP LYAR AP3B1 PGD SRPRB PRDM2 MKI67 TAGLN2 PRKDC LTF IK SNRPB NUP153 | 8.67e-06 | 1334 | 101 | 20 | int:BIRC3 |
| Interaction | USP36 interactions | NPM1 BRPF3 ABCF1 NOP53 KRI1 LYAR RRS1 MKI67 PUM3 C3 PRKDC LTF FGFBP1 | 9.23e-06 | 599 | 101 | 13 | int:USP36 |
| Interaction | OBSL1 interactions | NPM1 ABCF1 MCPH1 NOP53 PPFIBP1 SNX29 RRS1 AHNAK MKI67 PUM3 TAGLN2 PRKDC IK POLQ SNRPB NUP153 | 1.02e-05 | 902 | 101 | 16 | int:OBSL1 |
| Interaction | DOT1L interactions | NPM1 MYH10 NOP53 DUT KRI1 BCCIP TFIP11 LYAR WIZ RRS1 MKI67 PUM3 PRKDC IK NUP153 | 1.15e-05 | 807 | 101 | 15 | int:DOT1L |
| Interaction | MEN1 interactions | NPM1 MYH10 NOP53 RANBP3 GPATCH1 DUT KRI1 BCCIP TFIP11 LYAR PARP14 WIZ RRS1 MKI67 PUM3 IK NUP153 | 1.32e-05 | 1029 | 101 | 17 | int:MEN1 |
| Interaction | RBM19 interactions | 1.55e-05 | 221 | 101 | 8 | int:RBM19 | |
| Interaction | DNAJA2 interactions | NPM1 MYH10 IFT172 DTL APEH PGD EML5 N4BP2 MKI67 N4BP2L2 PRKDC EXOC4 | 1.72e-05 | 542 | 101 | 12 | int:DNAJA2 |
| Interaction | MAK16 interactions | 1.74e-05 | 162 | 101 | 7 | int:MAK16 | |
| Interaction | KIF20A interactions | NPM1 BRPF3 MYH10 ABCF1 DYNC2H1 PPFIBP1 COPB2 TFIP11 LYAR LACTB RRS1 AHNAK MKI67 PUM3 PRKDC IK SNRPB | 1.76e-05 | 1052 | 101 | 17 | int:KIF20A |
| Interaction | RPF2 interactions | 2.49e-05 | 236 | 101 | 8 | int:RPF2 | |
| Interaction | PRC1 interactions | NPM1 MYH10 ABCF1 TFIP11 LYAR ZZEF1 LACTB RRS1 AHNAK HASPIN MKI67 PUM3 PRKDC IK SNRPB NUP153 | 2.59e-05 | 973 | 101 | 16 | int:PRC1 |
| Interaction | SRPK1 interactions | 2.72e-05 | 477 | 101 | 11 | int:SRPK1 | |
| Interaction | MPHOSPH10 interactions | 2.76e-05 | 174 | 101 | 7 | int:MPHOSPH10 | |
| Interaction | HECTD1 interactions | NPM1 MYH10 ABCF1 NOP53 GPATCH1 COPB2 BARD1 KRI1 LYAR TTF1 RRS1 MKI67 PUM3 PRKDC IK EXOC4 | 2.97e-05 | 984 | 101 | 16 | int:HECTD1 |
| Interaction | OAS3 interactions | 3.07e-05 | 72 | 101 | 5 | int:OAS3 | |
| Interaction | ADARB1 interactions | NPM1 NOP53 TFIP11 LYAR TTF1 ZNF800 RRS1 AHNAK MKI67 PUM3 NUP153 | 3.41e-05 | 489 | 101 | 11 | int:ADARB1 |
| Interaction | POLR1G interactions | 3.41e-05 | 489 | 101 | 11 | int:POLR1G | |
| Interaction | SMC5 interactions | NPM1 SLF1 NOP53 GPATCH1 KRI1 TFIP11 LYAR WIZ RRS1 AHNAK MKI67 PUM3 PRKDC IK SNRPB NUP153 | 3.61e-05 | 1000 | 101 | 16 | int:SMC5 |
| Interaction | MNDA interactions | 4.52e-05 | 188 | 101 | 7 | int:MNDA | |
| Interaction | NMNAT1 interactions | 4.52e-05 | 128 | 101 | 6 | int:NMNAT1 | |
| Interaction | DDX31 interactions | 4.56e-05 | 257 | 101 | 8 | int:DDX31 | |
| Interaction | FGFBP1 interactions | 4.56e-05 | 257 | 101 | 8 | int:FGFBP1 | |
| Interaction | UTP23 interactions | 4.99e-05 | 191 | 101 | 7 | int:UTP23 | |
| Interaction | NPM3 interactions | 5.22e-05 | 262 | 101 | 8 | int:NPM3 | |
| Interaction | NIFK interactions | 6.12e-05 | 431 | 101 | 10 | int:NIFK | |
| Interaction | CHD4 interactions | NPM1 MYH10 ABCF1 MCPH1 KRI1 TFIP11 LYAR CPNE5 WIZ AHNAK MKI67 PUM3 PRKDC LTF IK | 6.54e-05 | 938 | 101 | 15 | int:CHD4 |
| Interaction | SIRT6 interactions | NPM1 ABCF1 GPATCH1 METTL1 WIZ RRS1 HASPIN MKI67 N4BP2L2 PUM3 PRKDC NUP153 | 7.17e-05 | 628 | 101 | 12 | int:SIRT6 |
| Interaction | RPA4 interactions | 9.07e-05 | 452 | 101 | 10 | int:RPA4 | |
| Interaction | NPM1 interactions | ALKBH4 NPM1 MYH10 NOP53 BARD1 KRI1 BCCIP LYAR NEB TTF1 ZNF800 RRS1 WDR87 TLE1 MKI67 PUM3 PRKDC | 9.24e-05 | 1201 | 101 | 17 | int:NPM1 |
| Interaction | ARL4D interactions | 9.39e-05 | 146 | 101 | 6 | int:ARL4D | |
| Interaction | NOP53 interactions | 1.01e-04 | 288 | 101 | 8 | int:NOP53 | |
| Interaction | RBM34 interactions | 1.06e-04 | 290 | 101 | 8 | int:RBM34 | |
| Interaction | RICTOR interactions | NPM1 MYH10 ABCF1 RANBP3 GPATCH1 SRPRB WIZ RRS1 AHNAK TAGLN2 PRKDC IK EXOC4 | 1.06e-04 | 759 | 101 | 13 | int:RICTOR |
| Interaction | MYBBP1A interactions | 1.11e-04 | 463 | 101 | 10 | int:MYBBP1A | |
| Interaction | ATR interactions | 1.11e-04 | 217 | 101 | 7 | int:ATR | |
| Interaction | NOL12 interactions | 1.21e-04 | 153 | 101 | 6 | int:NOL12 | |
| Interaction | OASL interactions | 1.32e-04 | 223 | 101 | 7 | int:OASL | |
| Interaction | KRI1 interactions | 1.39e-04 | 225 | 101 | 7 | int:KRI1 | |
| Interaction | DDX23 interactions | 1.48e-04 | 480 | 101 | 10 | int:DDX23 | |
| Interaction | NLE1 interactions | 1.51e-04 | 228 | 101 | 7 | int:NLE1 | |
| Interaction | GPATCH4 interactions | 1.68e-04 | 232 | 101 | 7 | int:GPATCH4 | |
| Interaction | TSC22D1 interactions | 1.78e-04 | 104 | 101 | 5 | int:TSC22D1 | |
| Interaction | KIF23 interactions | NPM1 MYH10 ABCF1 MYO5B KRI1 LYAR SRPRB LACTB RRS1 AHNAK CCDC138 MKI67 PUM3 PRKDC SNRPB | 1.86e-04 | 1031 | 101 | 15 | int:KIF23 |
| Interaction | H2BC21 interactions | NPM1 BRPF3 BARD1 NEB TTF1 PRDM2 WIZ AHNAK MKI67 DDX60L PRKDC FYB1 | 1.88e-04 | 696 | 101 | 12 | int:H2BC21 |
| Interaction | TIGD6 interactions | 2.01e-04 | 23 | 101 | 3 | int:TIGD6 | |
| Interaction | DGCR8 interactions | 2.18e-04 | 242 | 101 | 7 | int:DGCR8 | |
| Interaction | CAPZB interactions | NPM1 BRPF3 MYH10 MYO5B PPFIBP1 COPB2 BCCIP LYAR AP3B1 SRPRB CCDC138 HASPIN MKI67 FYB1 EXOC4 | 2.24e-04 | 1049 | 101 | 15 | int:CAPZB |
| Interaction | AGR2 interactions | NPM1 MYH10 ABCF1 DYNC2H1 COPB2 WDR81 AP3B1 ZZEF1 PGD AHNAK C3 TAGLN2 PRKDC EML1 | 2.29e-04 | 934 | 101 | 14 | int:AGR2 |
| Interaction | TTF1 interactions | 2.31e-04 | 110 | 101 | 5 | int:TTF1 | |
| Interaction | RSL24D1 interactions | 2.31e-04 | 110 | 101 | 5 | int:RSL24D1 | |
| Interaction | MOV10 interactions | NPM1 CPNE8 MYO9A NOP53 PPFIBP1 RANBP3 WDR81 BARD1 APEH TFIP11 PGD FAM111B RRS1 N4BP2 MKI67 PUM3 TAGLN2 | 2.32e-04 | 1297 | 101 | 17 | int:MOV10 |
| Interaction | WDR74 interactions | 2.84e-04 | 115 | 101 | 5 | int:WDR74 | |
| Interaction | EFTUD2 interactions | NPM1 MYH10 ABCF1 EMC3 PPFIBP1 GPATCH1 COPB2 DUT KRI1 TFIP11 LYAR AP3B1 SRPRB AHNAK TAGLN2 PRKDC IK SNRPB | 2.88e-04 | 1449 | 101 | 18 | int:EFTUD2 |
| Interaction | PUM3 interactions | 2.92e-04 | 254 | 101 | 7 | int:PUM3 | |
| Interaction | FAM111A interactions | 3.00e-04 | 64 | 101 | 4 | int:FAM111A | |
| Interaction | GRK5 interactions | 3.11e-04 | 182 | 101 | 6 | int:GRK5 | |
| Interaction | PES1 interactions | 3.21e-04 | 258 | 101 | 7 | int:PES1 | |
| Interaction | UCHL3 interactions | 3.40e-04 | 185 | 101 | 6 | int:UCHL3 | |
| Interaction | REXO4 interactions | 3.44e-04 | 261 | 101 | 7 | int:REXO4 | |
| Interaction | FBL interactions | 3.58e-04 | 639 | 101 | 11 | int:FBL | |
| Interaction | MAGEB2 interactions | 3.73e-04 | 349 | 101 | 8 | int:MAGEB2 | |
| Interaction | RNF151 interactions | 3.87e-04 | 123 | 101 | 5 | int:RNF151 | |
| Interaction | HASPIN interactions | 3.87e-04 | 123 | 101 | 5 | int:HASPIN | |
| Interaction | GSK3B interactions | MYO9A PPFIBP1 COPB2 KRI1 APEH BCCIP LYAR SNX29 TLE1 CCDC138 MKI67 PRKDC LTF | 3.94e-04 | 868 | 101 | 13 | int:GSK3B |
| Interaction | ACE2 interactions | NPM1 CPNE8 MYH10 DTL COPB2 KRI1 PGD SRPRB MKI67 NCOA7 TAGLN2 PRKDC LTF SNRPB NUP153 | 3.94e-04 | 1106 | 101 | 15 | int:ACE2 |
| Interaction | CHD3 interactions | NPM1 MYH10 BARD1 KRI1 TFIP11 LYAR MKI67 PUM3 PRKDC LTF IK SNRPB | 4.03e-04 | 757 | 101 | 12 | int:CHD3 |
| Interaction | U2AF2 interactions | NPM1 RANBP3 BARD1 TFIP11 RRS1 AHNAK MKI67 TAGLN2 PRKDC IK SNRPB | 4.19e-04 | 651 | 101 | 11 | int:U2AF2 |
| Interaction | BCAS2 interactions | 4.22e-04 | 270 | 101 | 7 | int:BCAS2 | |
| Interaction | TOLLIP interactions | 4.41e-04 | 358 | 101 | 8 | int:TOLLIP | |
| Interaction | NDN interactions | 4.55e-04 | 453 | 101 | 9 | int:NDN | |
| Interaction | DDRGK1 interactions | NPM1 ABCF1 NOP53 COPB2 KRI1 BCCIP TFIP11 LYAR SRPRB LACTB RRS1 PUM3 PRKDC IK SNRPB EXOC4 | 4.67e-04 | 1249 | 101 | 16 | int:DDRGK1 |
| Interaction | RAD18 interactions | 4.84e-04 | 457 | 101 | 9 | int:RAD18 | |
| Interaction | NSD2 interactions | 5.02e-04 | 278 | 101 | 7 | int:NSD2 | |
| Interaction | SRP14 interactions | 5.10e-04 | 366 | 101 | 8 | int:SRP14 | |
| Interaction | RPF1 interactions | 5.35e-04 | 132 | 101 | 5 | int:RPF1 | |
| Interaction | NR2C2 interactions | NPM1 MYH10 ABCF1 KRI1 BCCIP TFIP11 LYAR AP3B1 TTF1 SRPRB RRS1 AHNAK MKI67 TAGLN2 PRKDC SNRPB NUP153 | 5.76e-04 | 1403 | 101 | 17 | int:NR2C2 |
| Interaction | LYAR interactions | 5.78e-04 | 373 | 101 | 8 | int:LYAR | |
| Interaction | SNAPC4 interactions | 5.78e-04 | 76 | 101 | 4 | int:SNAPC4 | |
| Interaction | NOP56 interactions | 5.79e-04 | 570 | 101 | 10 | int:NOP56 | |
| Interaction | LRRC31 interactions | 5.85e-04 | 205 | 101 | 6 | int:LRRC31 | |
| Interaction | PAK1IP1 interactions | 5.93e-04 | 135 | 101 | 5 | int:PAK1IP1 | |
| Interaction | CDKN1A interactions | 5.99e-04 | 375 | 101 | 8 | int:CDKN1A | |
| Interaction | SLFN11 interactions | 6.09e-04 | 376 | 101 | 8 | int:SLFN11 | |
| Interaction | CIBAR1 interactions | 6.34e-04 | 137 | 101 | 5 | int:CIBAR1 | |
| Interaction | IL17B interactions | 6.38e-04 | 78 | 101 | 4 | int:IL17B | |
| Interaction | KRR1 interactions | 6.42e-04 | 379 | 101 | 8 | int:KRR1 | |
| Interaction | TENT4B interactions | 6.55e-04 | 138 | 101 | 5 | int:TENT4B | |
| GeneFamily | WD repeat domain containing | 3.37e-07 | 262 | 64 | 9 | 362 | |
| GeneFamily | Copines | 3.50e-06 | 9 | 64 | 3 | 829 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NPM1 MYH10 SLF1 MYO9A BCCIP AP3B1 MKI67 N4BP2L2 PUM3 POLQ FYB1 PUS7L | 9.47e-06 | 656 | 102 | 12 | M18979 |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN | 9.66e-06 | 125 | 102 | 6 | M8930 | |
| Coexpression | GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN | 1.36e-05 | 200 | 102 | 7 | M3504 | |
| Coexpression | HALLMARK_E2F_TARGETS | 1.36e-05 | 200 | 102 | 7 | M5925 | |
| Coexpression | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 | 1.45e-05 | 281 | 102 | 8 | M4077 | |
| Coexpression | FISCHER_DREAM_TARGETS | SLF1 PHF19 DTL DUT BARD1 TTF1 FAM111B HASPIN MKI67 PRKDC POLQ SNRPB NUP153 EXOC4 | 2.34e-05 | 969 | 102 | 14 | M149 |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN | 5.31e-05 | 169 | 102 | 6 | M379 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NPM1 TRAF5 SLF1 PHF19 NOP53 KRI1 PARP14 MOB3A PRDM2 ZNF800 TRANK1 AHNAK N4BP2L2 IK FYB1 NUP153 TBCC | 6.05e-05 | 1492 | 102 | 17 | M40023 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP | 6.65e-05 | 176 | 102 | 6 | M8881 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN | 6.80e-05 | 56 | 102 | 4 | M19590 | |
| Coexpression | GSE14415_INDUCED_TREG_VS_TCONV_UP | 7.30e-05 | 179 | 102 | 6 | M2959 | |
| Coexpression | RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN | 9.74e-05 | 368 | 102 | 8 | M1859 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP | 1.17e-04 | 195 | 102 | 6 | M3184 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP | 1.34e-04 | 200 | 102 | 6 | M3509 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 1.34e-04 | 200 | 102 | 6 | M6625 | |
| Coexpression | GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN | 1.34e-04 | 200 | 102 | 6 | M3491 | |
| Coexpression | GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP | 1.34e-04 | 200 | 102 | 6 | M9881 | |
| Coexpression | GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN | 1.34e-04 | 200 | 102 | 6 | M5773 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | NPM1 SLF1 DTL BARD1 BCCIP TTF1 PGD NSG2 RRS1 N4BP2 CCDC138 MKI67 PRKDC POLQ NUP153 | 1.38e-04 | 1290 | 102 | 15 | M80 |
| Coexpression | GRADE_COLON_AND_RECTAL_CANCER_UP | 1.42e-04 | 290 | 102 | 7 | M16740 | |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 1.45e-04 | 68 | 102 | 4 | M41108 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL | 1.52e-04 | 129 | 102 | 5 | M41687 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | NPM1 ANXA13 DUT BARD1 TTF1 RRS1 MKI67 PUM3 PRKDC SNRPB NUP153 | 1.86e-04 | 761 | 102 | 11 | M11961 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 3.27e-05 | 417 | 102 | 10 | GSM399403_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ABCF1 SLF1 SWT1 MYO9A DYNC2H1 LYAR AP3B1 ZNF800 EML5 MKI67 N4BP2L2 PRKDC POLQ EXOC4 | 4.31e-05 | 831 | 102 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.83e-09 | 177 | 102 | 8 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 1.60e-08 | 194 | 102 | 8 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | severe_COVID-19-B_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.74e-08 | 196 | 102 | 8 | 1a2b7c3f00098e9b4c0659b8714a0e4cf9f86f27 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 1.95e-08 | 199 | 102 | 8 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.96e-08 | 163 | 102 | 7 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 1.49e-07 | 173 | 102 | 7 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-07 | 173 | 102 | 7 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-07 | 179 | 102 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.19e-07 | 183 | 102 | 7 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-07 | 190 | 102 | 7 | b65383e256b04122500b742caeed0b807793851e | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-07 | 190 | 102 | 7 | 89095d3e023269d89c82e3a73550f869e3f34201 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.92e-07 | 191 | 102 | 7 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.92e-07 | 191 | 102 | 7 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | CV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 3.03e-07 | 192 | 102 | 7 | a249787f7e2f50af49bd7d4752c411a067a5e3d3 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 3.14e-07 | 193 | 102 | 7 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.14e-07 | 193 | 102 | 7 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | normal-na-Lymphocytic_B|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.14e-07 | 193 | 102 | 7 | 5fe436b8da06c537b61d18aba8a24b0c8b1895bb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.25e-07 | 194 | 102 | 7 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.25e-07 | 194 | 102 | 7 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-07 | 194 | 102 | 7 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.36e-07 | 195 | 102 | 7 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 3.36e-07 | 195 | 102 | 7 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-07 | 195 | 102 | 7 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-07 | 195 | 102 | 7 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.48e-07 | 196 | 102 | 7 | c87499aa570f8fab878c4c015e47c711a3a21e9c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.48e-07 | 196 | 102 | 7 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 3.48e-07 | 196 | 102 | 7 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-07 | 197 | 102 | 7 | f7a8440d2b8b17d9726c6fe3dd383effbfebab13 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-07 | 197 | 102 | 7 | 5c67ed18fb92aec73c79f4db6d80cec777d9ba44 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.60e-07 | 197 | 102 | 7 | 368a7908435cb0d0feea135345e7179584a1e0cf | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 3.60e-07 | 197 | 102 | 7 | acd678586aa0e4375bc8fbcdaa1a796c8dd23885 | |
| ToppCell | COVID-19_Mild-Lymphoid_B|COVID-19_Mild / Disease group, lineage and cell class | 3.60e-07 | 197 | 102 | 7 | ff25c0e184bd0f068014bc3f5eba3aee17511b87 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.60e-07 | 197 | 102 | 7 | 7cae4f3eabfebce101de7bb7defb17d6c5360b58 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-07 | 198 | 102 | 7 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new|World / Primary Cells by Cluster | 3.73e-07 | 198 | 102 | 7 | 11d2d4d179bc31ef2897d7ceeaf9bed1b20cbdc0 | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 3.73e-07 | 198 | 102 | 7 | c65cdb54409087014125a76627e5efb5fe8dabc9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-07 | 198 | 102 | 7 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-new-9|World / Primary Cells by Cluster | 3.73e-07 | 198 | 102 | 7 | c724ef958e14e17a7d8c02b9f842510c0780f635 | |
| ToppCell | MS-IIF-Lymphocyte-B-B_intermediate|IIF / Disease, condition lineage and cell class | 3.73e-07 | 198 | 102 | 7 | d6b533c5e1d55e13b1e87ce3dbacb1564bcdcc64 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.73e-07 | 198 | 102 | 7 | 48d39018c56ea8ba972c72af8ece10cbeb48fbc8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.73e-07 | 198 | 102 | 7 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 3.86e-07 | 199 | 102 | 7 | 2e222e2e080bc2be63d0fdf285e1790676b911ef | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-07 | 199 | 102 | 7 | 0cae9c80c15542fd86a82d7b6d6a3ad690cee410 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 3.86e-07 | 199 | 102 | 7 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_naive|COVID-19_Mild / Disease, condition lineage and cell class | 3.99e-07 | 200 | 102 | 7 | e6a43eff47195e1d39530ad49ad908fc06a8b038 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_naive|Influenza_Severe / Disease, condition lineage and cell class | 3.99e-07 | 200 | 102 | 7 | 0e05600d725dc5cc9afccc11eedc60efa41e4e46 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-07 | 200 | 102 | 7 | 28c702449040ac15fe4e0c6340bb6f137e88539d | |
| ToppCell | NS-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.99e-07 | 200 | 102 | 7 | d51e5c8c154b073caaf0cc09a3a3c0aafd57e44b | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.99e-07 | 200 | 102 | 7 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_Macrophages|Biopsy_IPF / Sample group, Lineage and Cell type | 3.99e-07 | 200 | 102 | 7 | 8abb2c25422717e994468ac02d8260344341467f | |
| ToppCell | Control-Control-Lymphocyte-B-B_naive|Control / Disease, condition lineage and cell class | 3.99e-07 | 200 | 102 | 7 | 15e4b9956b9a0c2e6927a802e86e1cb4bb18b89a | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 3.99e-07 | 200 | 102 | 7 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.99e-07 | 200 | 102 | 7 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B|COVID-19_Mild / Disease, condition lineage and cell class | 3.99e-07 | 200 | 102 | 7 | 11b51dfca161342d92126e0a83d10864348ba3ef | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-06 | 153 | 102 | 6 | 6a2a2379238133ce0ad714af130ffe02dd317247 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 153 | 102 | 6 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-06 | 153 | 102 | 6 | faa442dd925b2b09919e93c492ccc3f19803ad24 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 157 | 102 | 6 | 1ccb07a38d3fb606ee5fbc0437655f49baaaa62c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-06 | 169 | 102 | 6 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-06 | 170 | 102 | 6 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 171 | 102 | 6 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 171 | 102 | 6 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.94e-06 | 173 | 102 | 6 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 174 | 102 | 6 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 174 | 102 | 6 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.14e-06 | 175 | 102 | 6 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 3.25e-06 | 176 | 102 | 6 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.58e-06 | 179 | 102 | 6 | e1bfd553c043ebc070ccf8545d489ba16d9b2ef4 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-06 | 180 | 102 | 6 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-06 | 180 | 102 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | IIH-cycling-|IIH / Condition, Cell_class and T cell subcluster | 3.81e-06 | 181 | 102 | 6 | 7f4fed9e296bc22cb5a1e6c8e3c4b641e97c3078 | |
| ToppCell | IIH-cycling|IIH / Condition, Cell_class and T cell subcluster | 3.81e-06 | 181 | 102 | 6 | ec3e782ce93dcfe1a54fb7284e4e39063614b0e2 | |
| ToppCell | normal-na-Lymphocytic_B-B_mem-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.94e-06 | 182 | 102 | 6 | ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.19e-06 | 184 | 102 | 6 | 6b2449ac65a2322aa0479fba0d89828f243aabbe | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.19e-06 | 184 | 102 | 6 | e90622b82fa7f16a1faaf7a4724c958f2d83341d | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 4.33e-06 | 185 | 102 | 6 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 4.33e-06 | 185 | 102 | 6 | df85ff34b796b403f2d0741771e9592e03657f6a | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 4.33e-06 | 185 | 102 | 6 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | URO-Lymphocyte-B|URO / Disease, Lineage and Cell Type | 4.46e-06 | 186 | 102 | 6 | c46ff4fc280b67a454ee9614e93c6854a5a400b8 | |
| ToppCell | lymphoid-B_cell-Naive_B_cell|World / Lineage, cell class and subclass | 4.60e-06 | 187 | 102 | 6 | 904ffd8cf4513e86fcd4c2b7faf24a34fbd2dce3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.60e-06 | 187 | 102 | 6 | d01926be1c8846a25fb6706e26b56b808b69f8f0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 187 | 102 | 6 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | lymphoid-B_cell|World / Lineage, cell class and subclass | 4.60e-06 | 187 | 102 | 6 | 2abbc01fd7f5b4e52113699625287893c991f8da | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.74e-06 | 188 | 102 | 6 | 229108e7e3db49e1cfd747d69e338394139d95b3 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 4.74e-06 | 188 | 102 | 6 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.74e-06 | 188 | 102 | 6 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.74e-06 | 188 | 102 | 6 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue | 4.74e-06 | 188 | 102 | 6 | 714ccbcf826f26d39757931a3b8abbd952f4cddc | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.89e-06 | 189 | 102 | 6 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.89e-06 | 189 | 102 | 6 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 4.89e-06 | 189 | 102 | 6 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-06 | 189 | 102 | 6 | 8a38baee58a27c2fa3f4bd131ab9f15723ed9295 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.04e-06 | 190 | 102 | 6 | 112706d64ee73b55dcf76f33ca064ab1fc6ce87f | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 5.04e-06 | 190 | 102 | 6 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | B_cell_maturation|World / Lineage and Cell class | 5.04e-06 | 190 | 102 | 6 | 301782283d0c604fb3b428a8ddf1f7cd8e63a90b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 5.04e-06 | 190 | 102 | 6 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 5.19e-06 | 191 | 102 | 6 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.19e-06 | 191 | 102 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.19e-06 | 191 | 102 | 6 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.19e-06 | 191 | 102 | 6 | b23fdcd3090df9f58310b4dc8f7dc0c6d6b33226 | |
| Disease | monocyte percentage of leukocytes | CYP8B1 RANBP3 KRI1 SNX29 WIZ FCGR2B AHNAK C3 PRKDC RUFY4 RAPGEFL1 | 4.21e-05 | 731 | 101 | 11 | EFO_0007989 |
| Disease | VACTERL association (implicated_via_orthology) | 1.72e-04 | 6 | 101 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | microcephaly (implicated_via_orthology) | 1.80e-04 | 32 | 101 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | plexin-B2 measurement | 4.11e-04 | 9 | 101 | 2 | EFO_0021867 | |
| Disease | malaria (implicated_via_orthology) | 4.11e-04 | 9 | 101 | 2 | DOID:12365 (implicated_via_orthology) | |
| Disease | birth weight | 4.53e-04 | 399 | 101 | 7 | EFO_0004344 | |
| Disease | Jeune thoracic dystrophy | 6.25e-04 | 11 | 101 | 2 | C0265275 | |
| Disease | Diarrhea | 6.25e-04 | 11 | 101 | 2 | C0011991 | |
| Disease | alkaline phosphatase measurement | GPATCH1 WDR81 BCAS1 AP3B1 FCGR2C ZNF800 TRANK1 FCGR2B AHNAK N4BP2L2 LTF | 7.15e-04 | 1015 | 101 | 11 | EFO_0004533 |
| Disease | Adenocarcinoma of lung (disorder) | 7.27e-04 | 206 | 101 | 5 | C0152013 | |
| Disease | matrix metalloproteinase measurement | 8.83e-04 | 13 | 101 | 2 | EFO_0004744 | |
| Disease | Short Rib-Polydactyly Syndrome | 8.83e-04 | 13 | 101 | 2 | C0036996 | |
| Disease | Saldino-Noonan Syndrome | 1.03e-03 | 14 | 101 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 1.03e-03 | 14 | 101 | 2 | C0024507 | |
| Disease | serum gamma-glutamyl transferase measurement | MYO9A IFT172 GPATCH1 FCGR2C TRANK1 FCGR2B RRS1 AHNAK C3 EXOC4 | 1.17e-03 | 914 | 101 | 10 | EFO_0004532 |
| Disease | Vertigo | 1.35e-03 | 139 | 101 | 4 | HP_0002321 | |
| Disease | basophil count | 1.38e-03 | 483 | 101 | 7 | EFO_0005090 | |
| Disease | basophil percentage of leukocytes | 1.52e-03 | 243 | 101 | 5 | EFO_0007992 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 1.53e-03 | 17 | 101 | 2 | EFO_0021969 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.56e-03 | 22 | 101 | 2 | C3711387 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 3.31e-03 | 25 | 101 | 2 | EFO_0021970 | |
| Disease | atrophic macular degeneration | 3.31e-03 | 25 | 101 | 2 | EFO_1001492 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FGKFSVKENKQLEKN | 536 | Q15361 | |
| PKVNFRKQKLKTEGF | 111 | Q9NXW9 | |
| EKSKGKAKPQNKFAA | 181 | Q8NE71 | |
| DKPRKSLFNDAGNKK | 126 | Q99728 | |
| KNFKEKKSFKPDFGA | 416 | P35606 | |
| KDKPLVKVTFFQNGK | 156 | P31994 | |
| KSRPGNKGKFVTKDQ | 51 | Q14512 | |
| FRKLFKKKNGNATGE | 821 | A8MVX0 | |
| PANREFKSEKGRNKF | 91 | P01024 | |
| FKKAKNGVKLQRSPD | 931 | Q9ULD4 | |
| SKKLKGPQKFQFDGD | 301 | P52209 | |
| SGPKIKAKKQGFDLN | 5031 | Q09666 | |
| PQGFDVDRDAKKLNK | 11 | P27216 | |
| KKKQNSKGLAPSVDF | 201 | Q9NZJ0 | |
| TPAGKAKQENSAKKF | 661 | O00203 | |
| RSKGQESFKKQEKTP | 221 | P06748 | |
| VFVFQKDKGQKSPAE | 16 | Q9H6Z4 | |
| NKFNKKRKFQPDGRS | 86 | Q15397 | |
| KEPKNSSFGFDINKE | 466 | Q9H306 | |
| EFFLEQTKKKGVKRP | 211 | Q9NZM5 | |
| FQDTGKKKPQVNAKD | 86 | Q86YW9 | |
| FNFKTPENDKRFQKK | 116 | Q8NEM0 | |
| KPKKLAFSNFGNLRK | 901 | Q86W92 | |
| GNKDFLPKTSFKKFI | 196 | Q5W064 | |
| NKDKTFRPKRKFEPG | 11 | Q96BX8 | |
| RNSKPGKKKNDFEQG | 276 | P83111 | |
| FVEAGKNNSKKKPSN | 226 | Q9P287 | |
| KEDYLNKKGNPKKFA | 1406 | Q5H9U9 | |
| SNFKPFAKDPEKQKR | 501 | Q9BRR8 | |
| KDKPLVKVTFFQNGK | 156 | P31995 | |
| QKNKGKFRVPKIAEF | 56 | Q9Y328 | |
| QKQAFPKLTGVKGKF | 166 | O15117 | |
| DFDNLSGKGKPLKKF | 216 | Q9NX36 | |
| KKRKSPFAAAVGQEK | 476 | Q8N9T8 | |
| GTKAFKQPAKRKLDA | 2881 | P46013 | |
| LFNFGKEKFEVKKGD | 201 | P33316 | |
| NKIEFKRPGKAANKD | 1696 | Q9UG01 | |
| KIKRKGFEFNLSFQK | 391 | Q86SP6 | |
| GKEKNKDKEFIPQAF | 266 | O43182 | |
| DKPGAKQFFQDKARF | 746 | Q460N5 | |
| LLFKNKGSFDPKNAK | 3066 | Q8NCM8 | |
| AAFFAKKKPQRPKNS | 426 | Q96A65 | |
| DGKKPQLKFASQRND | 381 | Q96M89 | |
| DKKGLSGKQNNFERK | 176 | Q9Y5R5 | |
| KRFLDFSKEPNGKIN | 641 | Q5THR3 | |
| PDNKEFAEKKFKEVA | 36 | P25686 | |
| EKKTEFRNSGPFAKN | 1086 | O75417 | |
| ANKLDKKDFFGKSDP | 156 | Q8IYJ1 | |
| FKKGQKLGKDSFPTQ | 356 | Q8TF76 | |
| ISAFDNVPRKKAKFQ | 101 | Q9NX58 | |
| APAFRDKKQGVSAKN | 16 | Q8IX19 | |
| NKKQGLFEKQEKPKF | 406 | O00423 | |
| AKEQLFFEAPRGKKQ | 1146 | Q05BV3 | |
| NNPEDGFFKKTKRKV | 81 | Q9P0I2 | |
| SPAKQFNIYKKDFGK | 426 | Q6SJ93 | |
| KFFKLDKGQEKVPGD | 196 | O75363 | |
| ANKLDKKDFFGKSDP | 166 | Q86YQ8 | |
| SKFQKPRQLKDKADF | 561 | P35580 | |
| PNGSRKVDFFKTGKK | 411 | Q9UNU6 | |
| NKLDKKDFFGKSDPF | 186 | Q9HCH3 | |
| FGPFVGDKKKRSQVK | 56 | Q13029 | |
| VNKGKKNRIAFKPSE | 911 | Q6ZN16 | |
| VKARKNPKKFEDVFD | 421 | Q8NAN2 | |
| GKKGKEFEFSQLPLK | 226 | Q9Y5M8 | |
| NFPPKKAIGNKDAKF | 716 | Q8TEQ0 | |
| RQAQEKFGKDKSPKF | 291 | P02788 | |
| FPKKSKENPRNFSDN | 151 | P37802 | |
| EKDINPFSKFKSINK | 316 | Q8NI08 | |
| PFSKFKSINKEKRQQ | 321 | Q8NI08 | |
| KENSKFTFKPDTNKD | 226 | Q9H0K6 | |
| GKSKIKFLFQNPDTK | 446 | Q9NSN8 | |
| QFDQKEQKSFLGPRK | 51 | Q6ZNE9 | |
| DEFRKIKPKNSKQAE | 46 | P14678 | |
| FQKKKKKVANFDPGT | 751 | O95785 | |
| LEDFSKRQQPKFKKD | 941 | Q15477 | |
| SSPNFGEKDKKERKT | 21 | Q5T5J6 | |
| KKLEKEFKQFAQLFG | 286 | O00463 | |
| AEKKRPKAESFFQTK | 166 | P13798 | |
| NGPEFSNDIKKRKVD | 216 | Q04724 | |
| KGDKEYRIFQKKPQF | 116 | Q8TB69 | |
| ESEKKGFNSQAKRFP | 46 | Q5TH74 | |
| KRKFQPLFGDFAAEK | 251 | Q15050 | |
| PNKGALAKVKNNFKD | 21 | Q5T6S3 | |
| LQPKKRFAFKTRGKD | 131 | Q15814 | |
| LKKPEDKKQLGDFFG | 426 | Q13123 | |
| EVKKDSKNDNFKFGL | 971 | P49790 | |
| ARIKAEKEKDNFKAP | 171 | Q9BQI6 | |
| IFEKFSGKDPNSKDN | 2256 | P78527 | |
| PVDFKQRNKADKGVS | 2016 | O43149 | |
| KTRKPKLSAGFDFKQ | 471 | Q2TB10 | |
| IKGSVFKKFEKNNLF | 286 | Q6NXT6 | |
| VKFDINFNLKNKEGK | 571 | O15050 | |
| KLPGKFKNLFRKFEN | 536 | Q9UHV5 | |
| FQKSPKQGRKAVQKE | 1396 | Q6ZQQ6 | |
| KQDDFPKDFGPRKLK | 106 | Q9UBB9 | |
| PKDKKEKRAQAQVEF | 66 | Q9UBP6 | |
| KSKFRLNKGDKQLDF | 401 | Q562E7 | |
| SVKENKGLFPERDFK | 61 | Q6P4I2 | |
| QKRPHKRDSFGKSFK | 186 | P51508 | |
| NLIKDPDKFQFGRTK | 731 | Q9ULV0 | |
| DRGGQKEKQKFNSEK | 151 | Q92802 | |
| AFGKQKSKSTLEKFP | 766 | Q86UW6 | |
| KKTEEFKQNGGKPYL | 1711 | Q86UW6 | |
| GTFNPEKGKQKLKNV | 2491 | B2RTY4 | |
| RENFDKEKGKTPKYN | 5796 | P20929 |